Grant ID

98-RC-305-1

Illness

Bipolar Mania

Primary Drug/Intervention

Entacapone

Primary Dosage

>= 2000 mg/day

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Completed

Investigator

Walden

Sample Size

7

Duration of Study Period for Each Subject

N/A

Outcome Measurements

N/A

Results

Study was stopped after 7 patients due to lack of efficacy and complaints of dizzyness and gastrointestinal side effects.

Publication

N/A

Link

N/A

PI Name

Joerg Walden

Degree

MD

Center

N/A

Institution

N/A

Address

City or Town

Frieburg

State or Province

N/A

Zip or Postal Code

N/A

Country

Germany

Email Address

JOERG_WALDEN@psyallg.ukl.uni-freiburg.de